BRCA1 and cancer: However, in BRCA1 mutation carriers, BRCA1 haploinsufficiency-driven overexpression of RANK-L was observed, which correlated to the RANKL-addicted cancer stem cell-like behavior within cell populations with the BRCA1 mutation [274].